Cargando…

Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer’s disease

Background: Blood-based biomarkers may add a great benefit in detecting the earliest neuropathological changes in patients with Alzheimer’s disease (AD). We examined the utility of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) regarding clinical diagnosis and differentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parvizi, Tandis, König, Theresa, Wurm, Raphael, Silvaieh, Sara, Altmann, Patrick, Klotz, Sigrid, Rommer, Paulus Stefan, Furtner, Julia, Regelsberger, Günther, Lehrner, Johann, Traub-Weidinger, Tatjana, Gelpi, Ellen, Stögmann, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441692/ https://www.ncbi.nlm.nih.gov/pubmed/36072480 http://dx.doi.org/10.3389/fnagi.2022.887498

Ejemplares similares

Prescription patterns of antidementives in a high income country: A pharmacoepidemiologic study
por: Wurm, Raphael, et al.
Publicado: (2020)

Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes
por: Silvaieh, Sara, et al.
Publicado: (2023)

Correction: Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes
por: Silvaieh, Sara, et al.
Publicado: (2023)

Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy
por: Beerepoot, Shanice, et al.
Publicado: (2021)

Research trends and hotspots of glial fibrillary acidic protein within the area of Alzheimer’s disease: a bibliometric analysis
por: Zou, Yutong, et al.
Publicado: (2023)

Corrigendum: Research trends and hotspots of glial fibrillary acidic protein within the area of Alzheimer's disease: a bibliometric analysis
por: Zou, Yutong, et al.
Publicado: (2023)

Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL
por: Chen, Chih-Hao, et al.
Publicado: (2020)

Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria
por: Lotz-Havla, Amelie S., et al.
Publicado: (2022)

Increased risk of death associated with the use of proton‐pump inhibitors in patients with dementia and controls – a pharmacoepidemiological claims data analysis
por: Cetin, H., et al.
Publicado: (2020)

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2021)

Serum neurofilament light chain withstands delayed freezing and repeated thawing
por: Altmann, Patrick, et al.
Publicado: (2020)

Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases
por: Kim, Su-Hyun, et al.
Publicado: (2021)

Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2023)

Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity
por: Bose, Gauruv, et al.
Publicado: (2023)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
por: Vågberg, Mattias, et al.
Publicado: (2015)

Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas
por: Hepner, Adriana, et al.
Publicado: (2019)

Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury
por: Stukas, Sophie, et al.
Publicado: (2023)

Co‐incidental C9orf72 expansion mutation‐related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt−Jakob disease
por: Klotz, Sigrid, et al.
Publicado: (2020)

Neurofilaments contribution in clinic: state of the art
por: Delaby, Constance, et al.
Publicado: (2022)

Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury
por: Flynn, Spencer, et al.
Publicado: (2021)

Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder
por: Zhang, Tian-Xiang, et al.
Publicado: (2021)

Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury
por: Laverse, Etienne, et al.
Publicado: (2020)

Biological agents and the aging brain: glial inflammation and neurotoxic signaling
por: Latham, Amanda S., et al.
Publicado: (2023)

Teaching case 2-2019: Macrophagic scavenging of Aβ
por: Gelpi, Ellen, et al.
Publicado: (2019)

Modelling and Characterization of Glial Fibrillary Acidic Protein
por: Deka, Hemchandra, et al.
Publicado: (2015)

Autoimmune glial fibrillary acidic protein astrocytopathy
por: Kunchok, Amy, et al.
Publicado: (2019)

A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias
por: Bolsewig, Katharina, et al.
Publicado: (2022)

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study
por: Simone, Marta, et al.
Publicado: (2023)

Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke
por: Barba, Lorenzo, et al.
Publicado: (2023)

Clinical utility of serum glial fibrillary acidic protein in glial neoplasm
por: Yadav, Nidhi, et al.
Publicado: (2022)

Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients
por: Welford, Richard W.D., et al.
Publicado: (2022)

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4
por: Kessler, Christoph, et al.
Publicado: (2022)

Neurofilament Light Chain: A Candidate Biomarker of Perioperative Stroke
por: Zhang, Xiaoting, et al.
Publicado: (2022)

Longitudinal measurement of cerebrospinal fluid neurofilament light in anti‐N‐methyl‐D‐aspartate receptor encephalitis
por: Macher, Stefan, et al.
Publicado: (2020)

Glial fibrillary acidic protein in tumours of the nervous system.
por: Delpech, B., et al.
Publicado: (1978)

Glial fibrillary acidic protein is localized in the lens epithelium
Publicado: (1984)

Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure
por: Traub, Jan, et al.
Publicado: (2022)

Neurofilament light level correlates with brain atrophy, and cognitive and motor performance
por: Kartau, Marge, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jhkn389i8heqnpjf261vlv7d9l